Coumadin-induced hepatitis

Anna Leikin; Monir Merei; Eyal Dahan; Arnon Blum

doi:10.1016/j.ejim.2004.08.011

Coumadin-induced hepatitis

Anna Leikin
, Monir Merei
, Eyal Dahan
, Arnon Blum

Poriya Medical Center

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

The diagnosis of "coumadin-induced hepatitis" is compatible with the time relationship between the start of the drug and the onset of hepatopathy, the rapid improvement following discontinuation of the drug, recurrence of liver dysfunction after re-exposure to the drug and liver histology. Although liver damage induced by coumadin derivatives is rare, it is important to be aware of the hepatotoxic potential of these drugs, which, in most cases, mimic the clinical presentation of viral hepatitis.

Original language	English
Pages (from-to)	61-62
Number of pages	2
Journal	European Journal of Internal Medicine
Volume	16
Issue number	1
DOIs	https://doi.org/10.1016/j.ejim.2004.08.011
State	Published - Feb 2005
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Coumadin
Liver damage

Access to Document

10.1016/j.ejim.2004.08.011

Cite this

@article{822b3d8da79f4414b957b0442232b84f,

title = "Coumadin-induced hepatitis",

abstract = "The diagnosis of {"}coumadin-induced hepatitis{"} is compatible with the time relationship between the start of the drug and the onset of hepatopathy, the rapid improvement following discontinuation of the drug, recurrence of liver dysfunction after re-exposure to the drug and liver histology. Although liver damage induced by coumadin derivatives is rare, it is important to be aware of the hepatotoxic potential of these drugs, which, in most cases, mimic the clinical presentation of viral hepatitis.",

keywords = "Coumadin, Liver damage",

author = "Anna Leikin and Monir Merei and Eyal Dahan and Arnon Blum",

year = "2005",

month = feb,

doi = "10.1016/j.ejim.2004.08.011",

language = "אנגלית",

volume = "16",

pages = "61--62",

journal = "European Journal of Internal Medicine",

issn = "0953-6205",

publisher = "Elsevier B.V.",

number = "1",

}

TY - JOUR

T1 - Coumadin-induced hepatitis

AU - Leikin, Anna

AU - Merei, Monir

AU - Dahan, Eyal

AU - Blum, Arnon

PY - 2005/2

Y1 - 2005/2

N2 - The diagnosis of "coumadin-induced hepatitis" is compatible with the time relationship between the start of the drug and the onset of hepatopathy, the rapid improvement following discontinuation of the drug, recurrence of liver dysfunction after re-exposure to the drug and liver histology. Although liver damage induced by coumadin derivatives is rare, it is important to be aware of the hepatotoxic potential of these drugs, which, in most cases, mimic the clinical presentation of viral hepatitis.

AB - The diagnosis of "coumadin-induced hepatitis" is compatible with the time relationship between the start of the drug and the onset of hepatopathy, the rapid improvement following discontinuation of the drug, recurrence of liver dysfunction after re-exposure to the drug and liver histology. Although liver damage induced by coumadin derivatives is rare, it is important to be aware of the hepatotoxic potential of these drugs, which, in most cases, mimic the clinical presentation of viral hepatitis.

KW - Coumadin

KW - Liver damage

UR - https://www.scopus.com/pages/publications/14144251491

U2 - 10.1016/j.ejim.2004.08.011

DO - 10.1016/j.ejim.2004.08.011

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:14144251491

SN - 0953-6205

VL - 16

SP - 61

EP - 62

JO - European Journal of Internal Medicine

JF - European Journal of Internal Medicine

IS - 1

ER -

Coumadin-induced hepatitis

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this